to Evaluate the Efficacy and Safety of KLH-2109 in Patients With Uterine Fibroids and Menorrhagia
to Evaluate the Efficacy and Safety of KLH-2109 in Patients With Uterine Fibroids and Menorrhagia
Recruiting · NCT07378098 · Registry updated 2026-05-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| to Evaluate the Efficacy and Safety of KLH-2109 in Patients With Uterine Fibroids and Menorrhagia | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Fibroid Uterus, Genital Diseases, Hemorrhage, Menorrhagia, Menstruation Disturbances, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Uterine Hemorrhage, female reproductive system disorder, leiomyoma, myomatous neoplasm, neoplasm, uterine disorder | Recruiting | Phase 3 | 2026-05-01 | NCT07378098 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| JW Pharmaceutical | 9 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Asan Medical Center | Seoul | South Korea | 131 |